A. Ganser

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment

N. Schmitz, H. Heimpel, H. Döhner, 2015, Leukemia.

Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial

A. Ganser, G. Behre, A. Hinke, 2014, Bone Marrow Transplantation.

Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study

A. Ganser, P. Schöffski, H. Hecker, 1998, BMJ.

Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, ΔTrkA

A. Ganser, G. Reuther, B. Fehse, 2007, Leukemia.

DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia

L. Bullinger, K. Döhner, R. Schlenk, 2018, Leukemia.

Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group

L. Bullinger, K. Döhner, R. Schlenk, 2017, Leukemia.